BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1955 related articles for article (PubMed ID: 27481308)

  • 1. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation.
    Kappelman MD; Farkas DK; Long MD; Erichsen R; Sandler RS; Sørensen HT; Baron JA
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):265-73.e1. PubMed ID: 23602821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
    Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
    [No Abstract]   [Full Text] [Related]  

  • 4. Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan.
    Wang LH; Yang YJ; Cheng WC; Wang WM; Lin SH; Shieh CC
    Am J Gastroenterol; 2016 Sep; 111(9):1313-9. PubMed ID: 27296944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.
    Sokol H; Beaugerie L; Maynadié M; Laharie D; Dupas JL; Flourié B; Lerebours E; Peyrin-Biroulet L; Allez M; Simon T; Carrat F; Brousse N;
    Inflamm Bowel Dis; 2012 Nov; 18(11):2063-71. PubMed ID: 22271569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
    Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
    Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study.
    Charpentier C; Salleron J; Savoye G; Fumery M; Merle V; Laberenne JE; Vasseur F; Dupas JL; Cortot A; Dauchet L; Peyrin-Biroulet L; Lerebours E; Colombel JF; Gower-Rousseau C
    Gut; 2014 Mar; 63(3):423-32. PubMed ID: 23408350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.
    Müller KE; Lakatos PL; Arató A; Kovács JB; Várkonyi Á; Szűcs D; Szakos E; Sólyom E; Kovács M; Polgár M; Nemes É; Guthy I; Tokodi I; Tóth G; Horváth Á; Tárnok A; Csoszánszki N; Balogh M; Vass N; Bódi P; Dezsőfi A; Gárdos L; Micskey E; Papp M; Cseh Á; Szabó D; Vörös P; Veres G;
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):576-82. PubMed ID: 23820399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk in patients with inflammatory bowel disease: a population-based study.
    Bernstein CN; Blanchard JF; Kliewer E; Wajda A
    Cancer; 2001 Feb; 91(4):854-62. PubMed ID: 11241255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.
    Beaugerie L; Brousse N; Bouvier AM; Colombel JF; Lémann M; Cosnes J; Hébuterne X; Cortot A; Bouhnik Y; Gendre JP; Simon T; Maynadié M; Hermine O; Faivre J; Carrat F;
    Lancet; 2009 Nov; 374(9701):1617-25. PubMed ID: 19837455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory Bowel Disease Patients Are at Increased Risk of Invasive Pneumococcal Disease: A Nationwide Danish Cohort Study 1977-2013.
    Kantsø B; Simonsen J; Hoffmann S; Valentiner-Branth P; Petersen AM; Jess T
    Am J Gastroenterol; 2015 Nov; 110(11):1582-7. PubMed ID: 26346865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern Italy.
    Taborelli M; Sozzi M; Del Zotto S; Toffolutti F; Montico M; Zanier L; Serraino D
    PLoS One; 2020; 15(6):e0235142. PubMed ID: 32574216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Risk of Cancer and Mortality in a Large French Population-Based Paediatric-Onset Inflammatory Bowel Disease Retrospective Cohort.
    Dupont-Lucas C; Leroyer A; Ley D; Spyckerelle C; Bertrand V; Turck D; Savoye G; Maunoury V; Guillon N; Fumery M; Sarter H; Gower-Rousseau C;
    J Crohns Colitis; 2023 Apr; 17(4):524-534. PubMed ID: 36316987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
    So J; Tang W; Leung WK; Li M; Lo FH; Wong MTL; Sze ASF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Lam TY; Lam V; Lee TW; Lo HHH; Tang CM; Wong CL; Wu JCY; Chan FKL; Sung JJY; Harbord M; Ng SC
    Inflamm Bowel Dis; 2017 Nov; 23(11):2061-2068. PubMed ID: 28991855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
    Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
    Alexakis C; Saxena S; Chhaya V; Cecil E; Curcin V; Pollok R
    Inflamm Bowel Dis; 2017 Apr; 23(4):672-680. PubMed ID: 28151735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
    Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
    J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and cancer in pediatric-onset inflammatory bowel disease: a population-based study.
    Peneau A; Savoye G; Turck D; Dauchet L; Fumery M; Salleron J; Lerebours E; Ligier K; Vasseur F; Dupas JL; Mouterde O; Spyckerelle C; Djeddi D; Peyrin-Biroulet L; Colombel JF; Gower-Rousseau C
    Am J Gastroenterol; 2013 Oct; 108(10):1647-53. PubMed ID: 23939626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
    Kotlyar DS; Lewis JD; Beaugerie L; Tierney A; Brensinger CM; Gisbert JP; Loftus EV; Peyrin-Biroulet L; Blonski WC; Van Domselaar M; Chaparro M; Sandilya S; Bewtra M; Beigel F; Biancone L; Lichtenstein GR
    Clin Gastroenterol Hepatol; 2015 May; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.